Skip to content
Subscriber Only

Thirty Madison Vaults to Unicorn Status, Raises $140 Million

  • Health-care startup’s revenue has been surging, CEO says
  • Firm seeks to expand in the U.S. and, eventually, abroad
Michelle Carnahan, from left, Demetri Karagas, and Steven Gutentag
Michelle Carnahan, from left, Demetri Karagas, and Steven GutentagPhotographer: Jon Vachon

Thirty Madison, a health-care startup that specializes in treating chronic conditions, has raised $140 million in funding, valuing the company at more than $1 billion and granting it so-called unicorn status.

HealthQuest Capital led the funding round, which included participation by Mousse Partners and Bracket Capital, as well existing backers Polaris Partners, Johnson & Johnson Innovation - JJDC Inc., Greycroft and Northzone.